Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Chesnara Plc
Good 2023 results set platform for future progress
11th Apr 2024
Tissue Regenix
Six consecutive periods of >20% growth
10th Apr 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax enhanced research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
94: How governance enables startup growth and how to start it well | Dermot Campbell of SEEIO
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Advanced Oncotherapy
Life Sciences
Important regulatory milestone: ISO approval
By
Dr Gregoire Pave
21 Jan 2019
Allergy Therapeutics plc
Life Sciences
Trading update: gaining market share
By
Dr Dorothea Hill
17 Jan 2019
Stay up-to-date with the latest research
Sign up to our newsletter
1pm Plc
Financials
Interim results 1H FY’19: geared up for growth
By
Mark Thomas
16 Jan 2019
Diurnal Group Plc
Life Sciences
Chronocort – seeking regulatory advice
By
Dr Gregoire Pave
15 Jan 2019
Building & Construction
UK Housebuilding Sector in 2018
By
Tony Williams
14 Jan 2019
Volta Finance
Financials
Investment opportunities at this point of the cycle
By
Mark Thomas
14 Jan 2019
Life Sciences
Hardman & Co Healthcare Index
By
Dr Martin Hall
11 Jan 2019
The Monthly: January 2019
11 Jan 2019
Burford Capital
Financials
Next $1.6bn of investments to boost returns
By
Dr Brian Moretta
03 Jan 2019
Titon Holdings
Building & Construction
Good moon rising
By
Tony Williams
18 Dec 2018
Tissue Regenix
Life Sciences
2018 in review: foundations laid for osteobiologics
By
Dr Dorothea Hill
17 Dec 2018
Prev
1
...
51
52
53
54
55
...
74
Next